Literature DB >> 17458866

A novel VEGFR3 mutation causes Milroy disease.

Matthew G Butler1, Susan L Dagenais, Stanley G Rockson, Thomas W Glover.   

Abstract

Milroy disease, also known as primary congenital lymphedema, is a hereditary form of lymphedema with autosomal dominant inheritance. Individuals with Milroy disease are typically characterized by congenital onset of lymphedema of the lower limbs due to hypoplasia of the lymphatic vessels. The genetic basis of most cases of Milroy disease has not been established, although mutations in the vascular endothelial growth factor receptor VEGFR3 (FLT-4) are responsible for some cases with 17 mutations described to date. In this report, we describe a novel VEGFR3 mutation in exon 22 in a four-generation family in which congenital lymphedema segregates in an autosomal dominant manner. In addition to lymphedema, affected family members had other clinical manifestations associated with Milroy disease including hydrocele, ski jump toenails, large caliber veins, and subcutaneous thickening. We screened VEGFR3 for mutations which revealed a novel 3059A>T transversion in exon 22 resulting in Q1020L missense mutation in the second tyrosine kinase domain of VEGFR3. This mutant allele segregated with lymphedema among affected individuals with incomplete penetrance. This is the first report of an exon 22 mutation in Milroy disease. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458866     DOI: 10.1002/ajmg.a.31703

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

Review 1.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

Review 2.  Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Michael R Zalutsky; Alexander S Sobolev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 3.  The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.

Authors:  Guillermo Oliver; Jonathan Kipnis; Gwendalyn J Randolph; Natasha L Harvey
Journal:  Cell       Date:  2020-07-23       Impact factor: 41.582

Review 4.  Role of Transcriptional and Epigenetic Regulation in Lymphatic Endothelial Cell Development.

Authors:  Hyeonwoo La; Hyunjin Yoo; Young Bin Park; Nguyen Xuan Thang; Chanhyeok Park; Seonho Yoo; Hyeonji Lee; Youngsok Choi; Hyuk Song; Jeong Tae Do; Kwonho Hong
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

Review 5.  Lymphatic development.

Authors:  Matthew G Butler; Sumio Isogai; Brant M Weinstein
Journal:  Birth Defects Res C Embryo Today       Date:  2009-09

6.  Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Authors:  A Mendola; M J Schlögel; A Ghalamkarpour; A Irrthum; H L Nguyen; E Fastré; A Bygum; C van der Vleuten; C Fagerberg; E Baselga; I Quere; J B Mulliken; L M Boon; P Brouillard; M Vikkula
Journal:  Mol Syndromol       Date:  2013-08-21

7.  Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.

Authors:  F C Connell; P Ostergaard; C Carver; G Brice; N Williams; S Mansour; P S Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2008-11-12       Impact factor: 4.132

8.  VEGF-C improves regeneration and lymphatic reconnection of transplanted autologous lymph node fragments: An animal model for secondary lymphedema treatment.

Authors:  Lia Schindewolffs; Gerhard Breves; Manuela Buettner; Catarina Hadamitzky; Reinhard Pabst
Journal:  Immun Inflamm Dis       Date:  2014-11-17

9.  Four generations of rare familial lymphedema (Milroy disease).

Authors:  Sankalp Gokhale; Sanjay Gokhale
Journal:  Med Princ Pract       Date:  2013-06-04       Impact factor: 1.927

10.  A novel mutation in the conserved sequence of vascular endothelial growth factor receptor 3 leads to primary lymphoedema.

Authors:  Ting Dai; Bohan Li; Bo He; Liwei Yan; Liqiang Gu; Xiaolin Liu; Jian Qi; Ping Li; Xiang Zhou
Journal:  J Int Med Res       Date:  2018-06-13       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.